Author

M. Cybulska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

M. Mikula· 2 shared A. Jaiswar· 1 shared A. Szybinska· 1 shared A. Zylicz· 1 shared D. Walerych· 1 shared G. Zurawska· 1 shared J. Legierska· 1 shared J. R. Wisniewski· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

M. Mikula

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Impaired iron recycling from erythrocytes is an early iron-dependent hallmark of aging

P. Slusarczyk, P. K. Mandal, G. Zurawska, M. Niklewicz, K. Kumari Chouhan, M. Macias, A. Szybinska, M. Cybulska, O. Krawczyk, S. Herman, M. Mikula, R. Serwa, M. Lenartowicz, W. Pokrzywa, K. Mleczko-Sanecka

This study identifies impaired iron recycling by splenic red pulp macrophages as an early hallmark of aging and shows that reducing dietary iron improves iron turnover in aged mice.

bioRxiv · Jan 16, 2022Physiology

The response network of HSP70 defines vulnerabilities in cancer cells with the inhibited proteasome

M. Oron, M. Grochowski, A. Jaiswar, J. Legierska, K. Jastrzebski, M. Nowak-Niezgoda, M. Kolos, W. Kazmierczak, T. Olesinski, M. Lenarcik, M. Cybulska, M. Mikula, A. Zylicz, M. Miaczynska, K. Zettl, , D. Walerych

The paper identifies HSP70 as a vulnerability in cancer cells under proteasome inhibition, showing its role in suppressing drug effects and linking its expression to patient risk.

bioRxiv · Nov 16, 2021Cancer Biology